Ranjan Sinha, Founder, CEOranjan@3tandai.com

PROBLEM: “DIABESITY”“ Diabesity” = Obesity or Pre-diabetes or T2D or High TGL

Ravages 50 million Americans

1

The genetic risk and rates of disease variessignificantly across

ethnicity.

2

40/200

17/200

EVIDENCE AND RECOGNITION

Glycemic Index?

Low Carb Diet?

Low Fat Diet?

“...there is not a “One-Size-Fits-All" eating pattern for individuals with diabetes..”

~ American Diabetes Association , 2016

USDA FOOD CLOUD

PUBLIC GENOME &

BIOME DATA CLOUD

CORE TECHNOLOGY – PERSONALIZED WELLNESS PLATFORM

* optional

Search Across 500,000 Recipes

PERSONALIZED NUTRITION SOLUTIONS

BIOME

GENOTYPE

METABOLIC MARKERS

LIFESTYLE

BESPOKE FOOD SOLUTIONS

Curated Research

Heuristics

3TandAi Cloud

PRODUCTS

DTC(Gateway Product)

Nutrition, Exercise, Skin, Vitamin.

Recipe finder, Meal Planner.

“Want to Eat Better” + HEALTH RISK

B2B2C Wellness Program

Sold only through MDs, Dieticians and Wellness

Professionals

B2B2CPersonalized Corporate

Wellness Program

16 week Program

Engage health insurance and corporate food

partners

Direct Sales Force

MARKET SEGMENTS AND POTENTIAL –DIABESITY

Indian/South Asians

700K$1.7B

Chinese

650K$1.6B

Filipino

530K$1.3B

White

16m$38B

Mexicans

10m$24B African

American

6m$15B

RISK

COMPETITION

Habit Day Two DNA FitOmada Health

Virta Vida

GENETIC DATA Y Y X Y X X X

GUT BIOME DATA Y X Y X X X X

ETHNIC SPECIFIC MARKERs Y X X X X X X

PERSONALIZED NUTRITION Y Y Y Y X X X

OFFERS DIABESITY Y X X X Y Y Y

GENERAL WELLNESS X Y X Y X X X

CONDUCTING HUMAN TRIALS Y X Y X Y Y X

WORKS WITH BESPOKE FOOD MFG SYSTEMS

Y X X X X X X

FOCUSEDOn Diabesity

COMPREHENSIVEGenome

Biome

Metabolism

OPTIMIZEDFor ethnic

effectiveness

2 5

WHAT HAS BEEN ACHIEVED

SEED FUNDING PRODUCT

PRODUCT TEAM HUMAN TRIAL

PERSONALIZED FOOD

PROJECT

3D FOOD PRINTING

COMPANY

Convertible note

Live.

GeneratingRevenue.

CDC DPP

On board –Architect,

UXUI, Analysts, SW engineers

IRB Approved.

Starts April 15th.

Two corporate trial partners.

Research manager

hired.

Recruitment plan ready.

Phase Two USA Government

funded.

Starts July

Partnership signed.

Pilot productplanned for

Q4

THREE PHASE PLAN

Market GrowthScale Wellness and Bespoke food.275,000 ClientsIncorporate Medicare Participants

PHASE 22020-23

PHASE 12018-2019

Market EntryFinish Human trials (Pilot:April –Sept)

Establish BeachheadLaunch bespoke foods with partners5,000 Clients

PHASE 3Blue Sky Opportunities New health areas . International Marketplace – (2023-…

OUR TEAM + ADVISORS

PHILIP PANProduct Designer

UC Berkeley

Dr. JAEYUN SUNGBioinformatics Mayo Clinic

ROSHNI RAYScience and Research

OfficerUBiome

MIT; UC Berkeley

RANJAN SINHAFounder CEO

+ 4 software engineers

+ Analyst + Marketing

Dr. Sean Bourke MD

Dr. Rajesh DashMD, Phd

Dr. Ronesh SinhaMD

Dr. Cesar MolinaMD

Dr. Mima GeereMS NUTRITION

Dr. FahimAbbasi

MD

Dr. Akil PalanisamyMD

Dr. Larry KaskelMD

Dr. Ahmed El-Sohemy

Prof. Nutrition & Genes

Prajakta RanadeDiabetes NutritionistStanford Medical

Richard BlossomCEO Perfect Earth

Dr. Ken AlbalaFood Historian

Author

Dr. Abdur Rub, Phd

INVESTOR VALUE PROPOSITION

" 3TandAi blends individualized nutrition sciencewith knowledge of the culinary arts to provide aneasy to adopt personalized food platform. Theyare a PERFECT resource to prevent and reversechronic health conditions.

“Finally, we have a precise, trackable dietarysolution that can be used by physicians andnutritionists to reduce the most criticalcardiovascular and metabolic risks”.

Dr. Rajesh Dash, MD, PhDStanford Medical

Dr. Ron Sinha, Dir. Corporate Wellness, Sutter Health.

1. +100B global market.

2. Well timed, superior, differentiated solution.

3. Proven business, technology team supported by MDs

4. Low Risk.

5. Large data set invaluable to the food industry.

6. Many blue sky opportunities

FINANCIAL PROJECTIONS

Financials – 3 Month Churn* Weightwatchers had 1.1 million active subscribers end of 2016 paying $53 per month

*

A) Total Kits Sold = 275,000 | B) Series A Cash takes us thru Dec. 2019 | C) Peak Operating Cash required - $ 13 M

Series Q3 2018 = $2.0M| Series B = $15 mil (Q4 2019)

UNIT SALES 2018 2019 2020 2021 2022

Total Kit Sales 822 5,685 22,943 65,267 180,822

Kits Sold thru Corporate Wellness Partnership 55 1,180 7,943 29,973 100,822

Total Revenue $253,036 $2,055,418 $9,037,959 $27,668,291 $78,745,880

Total COGS $171,700 $1,299,680 $4,354,276 $12,589,897 $35,545,407

Gross Profit $81,336 $755,738 $4,683,682 $15,078,394 $43,200,473

GROSS MARGIN 32% 37% 52% 54% 55%

Total Expense 1,145,667 4,617,325 9,401,356 16,559,059 29,399,100

Operating Profit $1,064,331 $3,861,588 $4,717,674 $1,480,664 $13,801,373

Year End Headcount 15 42 69 125 229

Market Share 0.0% 0.2% 0.6% 1.3% 3.0%

Functional Medicine

Fastest growing segment

Businesswants to invest in

preventive health

Consumerswant

empowerment

WHY NOW